Applied Therapeutics, Inc.
APLTDelisted Feb 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001697532
Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Applied Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −6 vs. Q3 2022
- Shares held
- 19.7M
- −2.99M (−13.2%) vs. Q3 2022
- Total value
- $15.1M
- −$6.02M (−28.6%) vs. Q3 2022
- New holders
- 5
- 6 more added
- Sold out
- 11
- 18 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 52 | $5.93M |
| Q3 2025 | 70 | $57.2M |
| Q2 2025 | 75 | $27.4M |
| Q1 2025 | 90 | $51.8M |
| Q4 2024 | 119 | $98.5M |
| Q3 2024 | 126 | $960.9M |
| Q2 2024 | 94 | $481.8M |
| Q1 2024 | 89 | $638.6M |
| Q4 2023 | 83 | $205.8M |
| Q3 2023 | 55 | $107.0M |
| Q2 2023 | 40 | $40.3M |
| Q1 2023 | 36 | $15.6M |
| Q4 2022 | 38 | $15.1M |
| Q3 2022 | 44 | $21.1M |
| Q2 2022 | 53 | $25.3M |
| Q1 2022 | 71 | $26.0M |
| Q4 2021 | 69 | $133.6M |
| Q3 2021 | 70 | $250.9M |
| Q2 2021 | 69 | $319.3M |
| Q1 2021 | 67 | $278.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Applied Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 388 | $0 | 0.00% | −1,646−80.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 84 | $64 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 129 | $98 | 0.00% | −329−71.8% | Reduced |
| Wells Fargo & Company | 268 | $204 | 0.00% | +7+2.7% | Added |
| Citigroup Inc | 293 | $223 | 0.00% | −101,652−99.7% | Reduced |
| Citadel Advisors LLC | 374 | $284 | 0.00% | +374 | New |
| Group One Trading, L.P. | 1,086 | $825 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3,121 | $2.37K | 0.00% | +2,481+387.7% | Added |
| Morgan Stanley | 4,480 | $3.41K | 0.00% | −15,597−77.7% | Reduced |
| Tower Research Capital LLC (TRC) | 5,078 | $4.00K | 0.00% | −5,368−51.4% | Reduced |
| Two Sigma Securities, LLC | 10,933 | $8.31K | 0.00% | +10,933 | New |
| UBS Group AG | 11,368 | $8.64K | 0.00% | −15,781−58.1% | Reduced |
| Perennial Investment Advisors, LLC | 11,600 | $8.82K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,707 | $13.5K | 0.00% | +17,707 | New |
| Susquehanna International Group, LLP | 21,931 | $16.7K | 0.00% | −809−3.6% | Reduced |
| Ergoteles LLC | 36,524 | $27.8K | 0.00% | −15,161−29.3% | Reduced |
| Northern Trust Corp | 50,960 | $38.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 58,800 | $44.7K | 0.00% | −50,000−46.0% | Reduced |
| Millennium Management LLC | 61,943 | $47.0K | 0.00% | −37,538−37.7% | Reduced |
| Acadian Asset Management LLC | 87,395 | $65.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 94,415 | $71.8K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 101,654 | $77.3K | 0.01% | +101,654 | New |
| Two Sigma Investments, LP | 177,773 | $135.1K | 0.00% | −3,828−2.1% | Reduced |
| Two Sigma Advisers, LP | 249,900 | $189.9K | 0.00% | +700+0.3% | Added |
| BlackRock Inc. | 293,781 | $223.3K | 0.00% | −234,265−44.4% | Reduced |
| Renaissance Technologies LLC | 317,978 | $242.0K | 0.00% | −16,311−4.9% | Reduced |
| Laurion Capital Management LP | 345,900 | $262.9K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 361,078 | $274.0K | 0.00% | +29,012+8.7% | Added |
| Artal Group S.A. | 400,000 | $304.0K | 0.02% | 00.0% | Unchanged |
| Bank of Montreal | 323,100 | $355.4K | 0.00% | +323,100 | New |
| Rock Springs Capital Management LP | 596,680 | $453.5K | 0.01% | −105,000−15.0% | Reduced |
| Point72 Asset Management, L.P. | 719,938 | $547.2K | 0.00% | −1,000,000−58.1% | Reduced |
| Vanguard Group Inc | 796,562 | $605.4K | 0.00% | +343,299+75.7% | Added |
| Alyeska Investment Group, L.P. | 1,268,052 | $963.7K | 0.01% | −1,945,161−60.5% | Reduced |
| Knoll Capital Management, LLC | 2,450,000 | $1.86M | 4.20% | +1,367,877+126.4% | Added |
| FMR LLC | 2,972,371 | $2.26M | 0.00% | −231,600−7.2% | Reduced |
| OrbiMed Advisors LLC | 3,050,921 | $2.32M | 0.04% | −1,199,079−28.2% | Reduced |
| Franklin Resources Inc | 4,775,484 | $3.63M | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 0 | $0 | 0.00% | −73,783−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −28,321−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,380−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,060−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −11,287−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −4,038−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −450−100.0% | Sold out |